MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
Huadong Zhao, Guoqiang Bao(Qinghai University), Shixiong Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Qiu(Beijing Tongren Hospital), Xiaomin Liu(Shanghai University), Chong Chen(Sun Yat-sen University), Hang Guo(Second Affiliated Hospital of Jilin University), Fan Dong(Zhejiang Chinese Medical University), Li Gong(Xi'an Medical University), Qike Huang(Xijing Hospital), Jianguo Lu(Air Force Medical University), Haili Tang(Tang Du Hospital)
PubMed
January 1, 2016
Cited by 31
Related Papers
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
|Fibrogenesis & Tissue Repair|2012|806
The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation
|Journal of Neuroinflammation|2018|207
The Appropriate Marker for Astrocytes: Comparing the Distribution and Expression of Three Astrocytic Markers in Different Mouse Cerebral Regions
|BioMed Research International|2019|168
Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus
|Journal of Endocrinological Investigation|2018|157